The Food and Drug Administration (FDA) is postponing the conduct of foreign inspections from March to April 2020, effective immediately.
This decision is made in relation to the COVID-19 outbreak, travel restrictions imposed on foreign visitors in certain countries and the importance of the health and safety of the public and our employees.
Rest assured that the FDA is vigilant in monitoring this outbreak and its impact to our operations. We will continue to evaluate and calibrate our approach in ensuring the safety, efficacy and quality of our health products during this outbreak.
For more information, and inquiries, please e-mail us at [email protected]
Attachment:-> FDA Advisory No. 2020-349